Pharma Pricing & Market Access Europe 2013 addressed the critical policy issues in developing the optimum pricing strategy for pharmaceutical products last March. Discussions revolved around topics involving policy challenges in market access, HTA practice effecting the market, and how innovative pricing and risk sharing models between industry and payers have changed.
At the event, Jim Furniss, Senior VP, Market Access, GfK Bridgehead gave a presentation entitled “Scarcity, value and price”
Download the presentation and learn:
- Scarcity and equity
- Market access and price for orphan drugs
- Some recent developments
- Conclusion: The times are changing
The 8th Annual Pharma Pricing and Market Access Outlook World Europe is the world's largest gathering of pharmaceutical pricing, market access and reimbursement professionals regularly attracting a high attendance.
To get involved, go to our website for more details